编号 |
产品名称 |
CAS号 |
规格 |
价格 |
|
| CM-6096 |
替考拉宁A2-2,≥90%
Teicoplanin A2-2,≥90% |
91032-26-7 |
| 5 mg |
询价 |
| 10 mg |
询价 |
| 25 mg |
询价 |
| 50 mg |
询价 |
|
|
| CM-4254 |
Luotonin F,≥98%
Luotonin F,≥98% |
244616-85-1 |
| 1 mg |
询价 |
| 5 mg |
询价 |
| 10 mg |
询价 |
| 25 mg |
询价 |
|
|
| CM-1707 |
6-姜酚,≥98%
6-Gingerol,≥98% |
23513-14-6 |
| 1 mg |
询价 |
| 5 mg |
询价 |
| 10 mg |
询价 |
| 25 mg |
询价 |
|
|
| CM-6067 |
酮麝香（麝香酮）,≥98%
Muscone,≥98% |
541-91-3 |
| 50 mg |
询价 |
| 100 mg |
询价 |
| 500 mg |
询价 |
| 1 g |
询价 |
|
|
| CM-6072 |
Pheophorbide a,≥90%
Pheophorbide a,≥90% |
15664-29-6 |
| 25 mg |
询价 |
| 50 mg |
询价 |
| 100 mg |
询价 |
|
|
| CM-0811 |
叶黄素,≥95%
Lutein,≥95% |
127-40-2 |
| 500μg |
询价 |
| 1 mg |
询价 |
| 5 mg |
询价 |
| 10 mg |
询价 |
|
|
| CM-6007 |
1,2,3,4,6-五没食子酰葡萄糖(β-五没食子酰葡萄糖),≥95%
1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose,≥95% |
14937-32-7 |
| 5 mg |
询价 |
| 10 mg |
询价 |
| 25 mg |
询价 |
|
|
| CM-9820 |
鼠尾草酸,≥95%
Carnosic Acid,≥95% |
3650-09-7 |
| 5 mg |
询价 |
| 10 mg |
询价 |
| 25 mg |
询价 |
| 50 mg |
询价 |
|
|
| CM-6406 |
矢车菊素-3-葡萄糖苷,≥95%
Kuromanin chloride,≥95% |
7084-24-4 |
|
|
| CM-1832 |
柯里拉京,≥98%
Corilagin,≥98% |
23094-69-1 |
| 1 mg |
询价 |
| 5 mg |
询价 |
| 10 mg |
询价 |
| 25 mg |
询价 |
|
|
| CM-6001 |
玫瑰黄色素,≥95%
Roseoflavin,≥95% |
51093-55-1 |
| 1 mg |
询价 |
| 5 mg |
询价 |
| 10 mg |
询价 |
| 25 mg |
询价 |
|
|
| CM-5959 |
野黑樱苷,≥95%
(R)-Prunasin,≥95% |
99-18-3 |
|
|
| CM-5331 |
人参皂苷Rg2 ,≥98%
Ginsenoside Rg2,≥98% |
52286-74-5 |
| 500μg |
询价 |
| 1 mg |
询价 |
| 5 mg |
询价 |
| 10 mg |
询价 |
|
|
| BIA-A1587 |
阿维菌素B1a苷元 >95% by HPLC
Avermectin B1a aglycone,>95% by HPLC |
71828-14-3 |
|
|
| BIA-A1579 |
Δ2-阿维菌素B1a >95% by HPLC
Δ2-Avermectin B1a,>95% by HPLC |
NA |
|
|
| BIA-A1576 |
表阿维菌素B1a >95% by HPLC
epi-Avermectin B1a,>95% by HPLC |
106434-14-4 |
|
|
| BIA-A1585 |
Avermectin B1a monosaccharide,>95% by HPLC |
71831-09-9 |
|
|
| BIA-D1584 |
阿维菌素B1a单糖 >95% by HPLC
Doramectin aglycone,>95% by HPLC |
NA |
|
|
| BIA-D1580 |
Δ2-多拉菌素 >95% by HPLC
Δ2-Doramectin,>95% by HPLC |
NA |
|
|
| BIA-D1577 |
表多拉菌素 >95% by HPLC
epi-Doramectin,>95% by HPLC |
NA |
|
|
